Aiolos Bio
Biotechnology company focused on developing therapies for respiratory diseases. Acquired by GSK in January 2024 for approximately $1 billion.
Location
Waltham, Massachusetts, USA
Founded
2023
Categories
biotech, respiratory, immunology, acquired
